Suven Life Sciences Ltd

NSE: SUVEN · BSE: 530239 · Healthcare · 30 announcements

Share price: ₹305.55
Market cap: ₹8,634 Cr
Revenue (annual): ₹7.11 Cr
Net profit (annual): ₹-276.3 Cr
P/E (TTM): -24.5×Sector 53.1×
Promoter holding: 65.47%-4.68% QoQ
FII holding: 0.48%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 3 Business Update 3 Annual General Meeting 3 Board Meeting Outcome 2 Promoter Selling (Off-Market) 1 Management Change 1 Fund Raise 1 Financial Results 1 Employee Stock Options 1 Capital Structure Change 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

8 Jul 2026 15:00 IST NSE

Management Change

Suven Life Sciences Management Change

SUVEN Life Sciences Ltd re‑appointed Vajja Sambasiva Rao as a non‑executive independent director. The appointment is effective from 21 Jan 2027 for a 60‑month term.

Read the filing ↗